Category: Advocacy
-
Webinar: Consultation with stakeholders for the development of the request for the joint TB / HIV grant to the Global Fund – Morocco
Under the leadership of the Coordinating Committee (CCM) made up of representatives from different sectors, regularly renewed and allowing the involvement and full participation of representatives of key populations in Morocco. Grant applications have always been prepared with a broad consensus. The culture of concertation through a permanent Country Dialogue process has been maintained despite…
-
Morocco: National Generic Drug Companies banned by the American laboratory GILEAD from producing anti-COVID-19 treatments
ALCS – AMDH – ITPC-MENA Joint Press Release Casablanca May 13, 2020 Moroccan civil society calls for government use licenses as national generics manufactures are banned from producing anti-COVID19 drugs by GILEAD On May 12, 2020, U.S. laboratory Gilead announced voluntary licenses to five generics manufacturers in India and Pakistan allowing them to produce and…
-
Initiative 5%: Call for proposal on operational research “ Improvement in tuberculosis screening, treatment and prevention”
Source: Initiative 5% website The 5% Initiative is the second mechanism for France’s contribution to the Global Fund to Fight AIDS, Tuberculosis and Malaria (GF). The operational implementation of this Initiative has been entrusted to Expertise France ( the French Agency for International Technical Expertise) under the supervision of the Ministry for Europe and Foreign…
-
WHAT IS MISSING FROM THE UNITED NATIONS POLITICAL DECLARATION ON TUBERCULOSIS?
Source : ITPC GLOBAL (New York) — Today, UN Member States will come together at the UN Headquarters in New York City for the first “High Level Meeting” on TB, where countries will ratify a political declaration on tuberculosis (TB). Despite pressure, and securing several concrete pledges on expanding service delivery, the declaration falls short…
-
The MENA Community Advisory Board (MENA-CAB) 2017 Report
The Community Advisory Board (CAB) constitutes a space of exchange between advocates from the MENA region, researchers and drug manufacturers, with the aim to educate people living with HIV and their advocates on access to treatment, to disseminate information about research and drug development and to discuss access strategies. The organisation of the CABs is…
-
HRC38: Human Rights Council set to adopt resolution on Human rights in the context of HIV and AIDS
On Thursday, 28 June 2018, the delegations of Brazil, Colombia, Mozambique, Portugal, and Thailand submitted a draft resolution on “Human rights in the context of HIV and AIDS” to the 38th session of the Human Rights Council. The text of the draft resolution can be found (at the end of the page). The Core Group…
-
Civil Society Speaks: Fighting for Universal Access To Dolutegravir (DTG)!
Source : The Global Network of People living with HIV GNP+ What do people living with HIV need to know about Dolutegravir? What do our communities need to know about viral resistance to first line ARVs? GNP+ invites you to an important treatment access discussion on accelerating the roll out of Dolutegravir, a groundbreaking alternative…
-
Global Fund MENA Regional Platform is relaunched
ITPC-MENA continues as the host for the Middle East and North Africa region As a key component of the Global Fund’s Community, Rights and Gender Strategic Initiative, the Regional Platform for Communication and Coordination will continue to support and facilitate civil society dialogue and engagement with Global Fund grants and processes. ITPC-MENA, which hosted the…
-
ITPC-MENA at the launch of the new report on human rights and HIV in Africa by the African Commission on Human and Peoples’ Rights
African Commission on Human and Peoples’ Rights to launch report on human rights and HIV in Africa ‘HIV, the Law and Human Rights in the African Human Rights System: Key Challenges and Opportunities for Rights-based Responses to HIV’ to be launched on the side-lines of the African Union Summit Protecting the human rights of people…
-
New Study : Assessment of national intellectual property landscapes and their impact on access to medicines (Egypt, Morocco, Tunisia)
Title: A tool to assess how friendly to access-to-medicines your law is Background Provisions of intellectual property (IP) may have an important impact on access to medicines. For instance, the monopoly granted by the patent prevents competition with generics on the market and is often responsible for high prices. Along the years, IP provisions grow…